Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| RxSight, Inc.RXST · Entity 1226 | Director | June 17, 2026 | June 18, 2026 |
| Sight Sciences, Inc.SGHT · Entity 5537 | Director | June 04, 2026 | June 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
RxSight, Inc.
Report date June 17, 2026 · Filed June 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 72,582 |
Reported balance
After 2026-06-17 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-17 · Grant · Acquired 37,037 · Balance 72,582 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. F2: Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the date of the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 17, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock.
F2: Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the date of the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 17, 2026.
Sight Sciences, Inc.
Report date June 04, 2026 · Filed June 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 109,650 |
Reported balance
After 2026-06-04 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-04 · Grant · Acquired 28,261 · Balance 109,650 F1: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to approximately $130,000 of shares of Common Stock as determined by the closing price on the grant date, June 4, 2026. The RSUs vest on the earlier of June 4, 2027 and the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service as a director on the Company's board of directors through such vesting date. F2: Includes (i) 81,389 shares of Common Stock and (ii) 28,261 RSUs which are subject to vesting as reported herein. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to approximately $130,000 of shares of Common Stock as determined by the closing price on the grant date, June 4, 2026. The RSUs vest on the earlier of June 4, 2027 and the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service as a director on the Company's board of directors through such vesting date.
F2: Includes (i) 81,389 shares of Common Stock and (ii) 28,261 RSUs which are subject to vesting as reported herein.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 17, 2026 Filed Jun 18, 2026 20:09 UTC | RxSight, Inc. RXST · Entity 1226 | GrantCommon Stock | 37,037 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-275843 · ownership.xml · nonDerivative · entry 1 Fountain Tamara · CIK 0001902243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,582 F1 · security: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. F2 · shares: Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the date of the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 17, 2026. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 20:10 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | GrantCommon Stock | 28,261 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-259573 · ownership.xml · nonDerivative · entry 1 Fountain Tamara · CIK 0001902243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,650 F1 · shares: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to approximately $130,000 of shares of Common Stock as determined by the closing price on the grant date, June 4, 2026. The RSUs vest on the earlier of June 4, 2027 and the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service as a director on the Company's board of directors through such vesting date. F2 · balance_after: Includes (i) 81,389 shares of Common Stock and (ii) 28,261 RSUs which are subject to vesting as reported herein. Read SEC document |
| June 05, 2025 Filed Jun 10, 2025 01:53 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | GrantCommon Stock | 30,952 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-084071 · ownership.xml · nonDerivative · entry 1 Fountain Tamara · CIK 0001902243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,389 F1 · shares: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to approximately $130,000 of shares of Common Stock as determined by the closing price on the grant date, June 5, 2025. The RSUs vest on the earlier of June 5, 2026 and the date of the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person's continued service as a director on the Company's board of directors through such vesting date. F2 · balance_after: Includes (i) 44,444 shares of Common Stock, (ii) 30,952 RSUs which are subject to vesting as reported herein, and (iii) 5,993 RSUs granted to the Reporting Person on January 8, 2023 which are subject to vesting as previously reported. Read SEC document |
| June 03, 2025 Filed Jun 5, 2025 01:38 UTC | RxSight, Inc. RXST · Entity 1226 | GrantCommon Stock | 10,752 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-081961 · ownership.xml · nonDerivative · entry 1 Fountain Tamara · CIK 0001902243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,545 F1 · security: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. F2 · shares: Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the date immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 3, 2025. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. Read SEC document |
| March 12, 2025 Filed Mar 13, 2025 20:46 UTC | RxSight, Inc. RXST · Entity 1226 | SaleCommon Stock | 7,000 | $25.71 | $180,001.50 |
DisclosureSEC source: 0000950170-25-038834 · ownership.xml · nonDerivative · entry 1 Fountain Tamara · CIK 0001902243 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,793 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan established on December 11, 2024 by the Reporting Person. F2 · price: Represents the weighted average share price of an aggregate total of 7,000 shares sold in the price range of $25.355 to $26.175 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 06, 2024 Filed Jun 10, 2024 20:14 UTC | RxSight, Inc. RXST · Entity 1226 | GrantCommon Stock | 2,554 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-071299 · ownership.xml · nonDerivative · entry 1 Fountain Tamara · CIK 0001902243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,793 F1 · security: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. F2 · shares: Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of the (i) the one (1) year anniversary of the Date of Grant or (ii) the date immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 6, 2024. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. Read SEC document |
| June 06, 2024 Filed Jun 10, 2024 23:35 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | GrantCommon Stock | 17,366 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-071526 · ownership.xml · nonDerivative · entry 1 Fountain Tamara · CIK 0001902243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,437 F1 · shares: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to $120,000 divided by the closing price of the Common Stock on the grant date, June 6, 2024. The RSUs vest on the earlier of June 6, 2025 and the date of the Issuer's 2025 annual meeting of stockholders, subject to the Reporting Person's continued service as a director on the Company's board of directors through such vesting date. F2 · balance_after: Includes (i) 21,086 shares of Common Stock, (ii) 17,366 RSUs, which are subject to vesting as reported herein, and (iii) 11,985 RSUs granted to the Reporting Person on January 8, 2023, which are subject to vesting as previously reported. Read SEC document |
| June 08, 2023 Filed Jun 12, 2023 21:45 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | GrantCommon Stock | 15,094 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-015386 · doc4.xml · nonDerivative · entry 1 Fountain Tamara · CIK 0001902243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · shares: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to approximately $120,000 of shares of Common Stock as determined by the closing price on the grant date, June 8, 2023. The RSUs vest on the earlier of June 8, 2024 and the date of the Issuer's 2024 annual meeting of stockholders, subject to the Reporting Person's continued service as a director on the Company's board of directors through such vesting date. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 20:30 UTC | RxSight, Inc. RXST · Entity 1226 | GrantCommon Stock | 5,731 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-034316 · doc4.xml · nonDerivative · entry 1 Fountain Tamara · CIK 0001902243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,239 F1 · security: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. F2 · shares: Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of the (i) the one (1) year anniversary of the Date of Grant or (ii) the date immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 2, 2022. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. Read SEC document |
| January 19, 2023 Filed Jan 23, 2023 21:26 UTC | RxSight, Inc. RXST · Entity 1226 | GrantCommon Stock | 4,312 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-004409 · doc4.xml · nonDerivative · entry 2 Fountain Tamara · CIK 0001902243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,508 F1 · security: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. F3 · shares: Subject to the Reporting Person's continuing as an Outside Director through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of the (i) the one (1) year anniversary of the Date of Grant or (ii) the date of the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean January 19, 2023. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. Read SEC document |
| January 19, 2023 Filed Jan 23, 2023 21:26 UTC | RxSight, Inc. RXST · Entity 1226 | GrantCommon Stock | 19,196 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-004409 · doc4.xml · nonDerivative · entry 1 Fountain Tamara · CIK 0001902243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,196 F1 · security: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. F2 · shares: Subject to the Reporting Person's continuing service as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one third of the RSUs subject to the award shall vest on each annual anniversary of January 2, 2022. Consequently, one third of the RSUs subject to the award were settled immediately upon the date of grant. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. Read SEC document |
| January 08, 2023 Filed Jan 10, 2023 23:43 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | GrantCommon Stock | 17,977 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-001508 · doc4.xml · nonDerivative · entry 1 Fountain Tamara · CIK 0001902243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person on under the Issuer's 2021 Incentive Award Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest and become exercisable in substantially equal installments on each of January 1, 2024, 2025, and 2026, subject to the Reporting Person's continued service as a director on the Company's board of directors through each such vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.